Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 8, 2014, Pages

  Price, Michelle ^a   Günther, Albrecht ^b   Kwan, Joseph S K ^c  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADVERSE EVENT; CEREBROVASCULAR DISEASE; DAILY LIFE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; FOLLOW UP; HOSPITALIZATION; HUMAN; INTRACRANIAL VENOUS THROMBOSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SECONDARY PREVENTION; SEIZURE; SYSTEMATIC REVIEW; TREATMENT DURATION; OCCLUSIVE CEREBROVASCULAR DISEASE; VEIN THROMBOSIS;

ANTICONVULSANTS; HUMANS; INTRACRANIAL THROMBOSIS; SEIZURES; VENOUS THROMBOSIS;

EID: 84907169031     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005501.pub3     Document Type: Review

References (25)

1. Allroggen H, Abbot RJ. Cerebral venous sinus thrombosis. Postgraduate Medical Journal 2000;76(891):12-5.
2. Arquizan C, Meder JF, Mas JL. Brain venous thrombosis syndromes. In: Bogousslavsky J, Caplan LR editor(s). Stroke syndromes. Second Edition. Cambridge: Cambridge University Press, 2002:626-50.
3. Benamer HTS, Bone I. Cerebral venous thrombosis: anticoagulants or thrombolytic therapy?. Journal of Neurology, Neurosurgery, and Psychiatry 2000;69(4):427-30.
4. Buccino G, Scoditti U, Patteri I, Bertolino C, Mancia D. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurologica Scandinavica 2003;107(5):330-5.
5. Canhão P, Ferro J, Massaro A, Camargo E. Corticosteroids for cerebral vein and dural sinus thrombosis. Cochrane Database of Systematic Reviews 2002, Issue 3.
6. Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F (ISCVT Investigators). Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36(8):1720-5.
7. Canhão P, Batista P, Falcao F. Lumbar puncture and dural sinus thrombosis - a causal or casual association?. Cerebrovascular Disease 2005;19(1):53-6.
8. Ciccone A, Canhão P, Falcao F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database of Systematic Reviews 2004, Issue 1. [DOI: 10.1002/14651858.CD003693.pub2]
9. Connor SEJ, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis. Clinical Radiology 2002;57(6):449-61.
10. Cumurciuc R, Crassard I, Sarov M, Valade D, Bousser MG. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. Journal of Neurology, Neurosurgery, and Psychiatry 2005;76(8):1084-7.
11. De Bruijn SF, De Hann RJ, Stam J. Clinical features and prognostic factors of cerebral venous thrombosis in a prospective series of 59 patients. Journal of Neurology, Neurosurgery, and Psychiatry 2001;70(1):105-8.
12. DeVeber G, Andrew M, Adams C, Bjornson B, Booth F, Buckley DJ, et al.Cerebral venous thrombosis in children. New England Journal of Medicine 2001;345(6):417-23.
13. Einhaupl KM, Masuhr F. Cerebral venous and sinus thrombosis: an update. European Journal of Neurology 1994;1(2):109-26.
14. Ferro JM, Correia M, Rosas MJ, Pinto AN, Neves G. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovascular Disease 2003;15(1-2):78-83.
15. Heller C, Heinecke A, Junker R, Knofler R, Kosch A, Kurnik K, et al.Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003;108(11):1362-7.
16. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]. The Cochrane Collaboration, 2005. Available from www.cochrane-handbook.org.
17. International League Against Epilepsy. Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22(4):489-501.
18. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
19. Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. Journal of Neurology 2004;251(1):11-23.
20. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996;27(2):243-6.
21. Stam J, De Bruijn SFTM, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD002005]
22. Stolz E, Rahimi A, Gerriets T, Kraus J, Kaps M. Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clinical Neurology and Neurosurgery 2005;107(2):99-107.
23. Terazzi R, Mittino D, Ruda R, Cerrato P, Monaco F, Sciolla R, et al.Cerebral venous thrombosis: a retrospective multicentre study of 48 patients. Neurological Science 2005;25(6):311-5.
24. Van den Bergh WM, Van der Schaaf I, Van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005;65(2):192-6.
25. Kwan J, Günther A. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD005501.pub2]